Brugen af Viraferon i kombination med ribavirin er endvidere blevet undersøgt hos 118 behandlingsnaive børn med hepatitis C i alderen 3– 16 år.
The use of Viraferon in combination with ribavirin has also been studied in 118 hepatitis C treatment-naïve children aged between three and 16 years.